Correlation Between Alto Neuroscience, and Titan Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Alto Neuroscience, and Titan Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alto Neuroscience, and Titan Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alto Neuroscience, and Titan Pharmaceuticals, you can compare the effects of market volatilities on Alto Neuroscience, and Titan Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alto Neuroscience, with a short position of Titan Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alto Neuroscience, and Titan Pharmaceuticals.
Diversification Opportunities for Alto Neuroscience, and Titan Pharmaceuticals
-0.45 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Alto and Titan is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Alto Neuroscience, and Titan Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Titan Pharmaceuticals and Alto Neuroscience, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alto Neuroscience, are associated (or correlated) with Titan Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Titan Pharmaceuticals has no effect on the direction of Alto Neuroscience, i.e., Alto Neuroscience, and Titan Pharmaceuticals go up and down completely randomly.
Pair Corralation between Alto Neuroscience, and Titan Pharmaceuticals
Given the investment horizon of 90 days Alto Neuroscience, is expected to under-perform the Titan Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Alto Neuroscience, is 1.33 times less risky than Titan Pharmaceuticals. The stock trades about -0.16 of its potential returns per unit of risk. The Titan Pharmaceuticals is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 364.00 in Titan Pharmaceuticals on December 1, 2024 and sell it today you would earn a total of 34.00 from holding Titan Pharmaceuticals or generate 9.34% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Alto Neuroscience, vs. Titan Pharmaceuticals
Performance |
Timeline |
Alto Neuroscience, |
Titan Pharmaceuticals |
Alto Neuroscience, and Titan Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Alto Neuroscience, and Titan Pharmaceuticals
The main advantage of trading using opposite Alto Neuroscience, and Titan Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alto Neuroscience, position performs unexpectedly, Titan Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Titan Pharmaceuticals will offset losses from the drop in Titan Pharmaceuticals' long position.Alto Neuroscience, vs. Modine Manufacturing | Alto Neuroscience, vs. Genfit | Alto Neuroscience, vs. Cardinal Health | Alto Neuroscience, vs. FDG Electric Vehicles |
Titan Pharmaceuticals vs. Salarius Pharmaceuticals | Titan Pharmaceuticals vs. SAB Biotherapeutics | Titan Pharmaceuticals vs. GeoVax Labs | Titan Pharmaceuticals vs. Senti Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |